Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Anktiva comment

<< Previous

Bullboard Posts

Next >>

Comment by menoalittleon Apr 26, 2024 7:27pm

212 Views

Post# 36010495

RE:RE:RE:Anktiva comment

Even if only 10% of that MC after BTD seems reasonable... perhaps a more interesting question is, what price seems just as (or more) reasonable for it to be at after the submission for BTD is announced? (Because I think the FDA is supposed to respond to that within 60 day, if I'm remembering right.)

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant